DJIA 18,070.40 46.34 0.26%
NASDAQ 5,016.93 11.54 0.23%
S&P 500 2,114.49 6.20 0.29%
market minute promo

XenoPort, Inc. (NASDAQ: XNPT)



company name or ticker

XenoPort - Upside Potential In Its Phase 2 Drug

XenoPort's (XNPT) CEO Ron Barrett on Q4 2014 Results - Earnings Call Transcript

XenoPort (XNPT) Q4 2014 Results - Earnings Call Webcast

Commit To Purchase XenoPort At $6, Earn 22.7% Annualized Using Options

Xenoport: Significant Growth Potential On Horizant Sales And A Solid Pipeline

Why XenoPort, Inc. Shares Tanked Today

XenoPort stock dives after announcing the completion of a convertible note offering. Find out why this note sale could be bad news for existing investors.

Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On

Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks

Xenoport (XNPT) Shares March Higher, Can It Continue? - Tale of the Tape

Xenoport (XNPT) Shares March Higher, Can It Continue? - Tale of the Tape

XenoPort Prepping For Key Data In 2015

See More Articles...